Evaluating the Effects of a Self-help Mobile Phone Application on Worry and Overthinking in Young Adults Aged Between 16 and 24.

Evaluating the Effects of a Self-help Mobile Phone Application on Worry and Rumination Experienced by Young Adults: a Preventative Intervention for Depression and Anxiety

This project seeks to understand if a new self-help mobile phone application (called MyMoodCoach) is effective at reducing worry and overthinking, prominent risk factors that predict reduced well-being and poor mental health. As a primary outcome, the investigators are predicting that people who use the app will report more significant reductions on measures of overthinking than those who do not. The investigators also predict that people who use the app will report more significant reductions in measures of worry as well as reported symptoms of depression and anxiety. Further, it is predicted that people who use the app will report a significantly higher increase in their well-being compared to those who do not.

Study Overview

• Status: Completed
• Conditions: Rumination; Worry; Repetitive Negative Thinking
• Intervention / Treatment: Device: digital CBT self-help including specific intervention elements to target worry and rumination.

Detailed Description

The Emotional Competence for Well-Being in Young Adults study has developed an emotional competence app to be examined via cohort multiple randomised controlled trial (cmRCT) in a longitudinal prospective cohort. This off-shoot study adapts the app to focus on targeting worry and overthinking (also known as rumination), which are prominent risk factors for poor mental health.

Within this study, 16-24-year-olds in the UK, who report elevated worry and rumination on standardised questionnaires are randomised to either receive the mobile phone app immediately or to receive the app after a wait of 6 weeks. In total, the study will aim to recruit 204 participants across the UK. Assessments take place at baseline (pre-randomisation), 6 and 12 weeks post-randomisation. Primary endpoint for the study is the change in levels of rumination assessed at 6 weeks after randomisation. Worry, depressive symptoms, anxiety symptoms and well-being are secondary outcomes. Compliance, adverse events, and potentially mediating variables will be carefully monitored.

This trial aims to provide a better understanding of the benefits of tackling rumination and worry via an intervention delivered via mobile phone app with respect to promoting well-being and preventing poor mental health in young people. This prevention mechanism trial will establish whether targeting worry and rumination directly via an app provides a feasible approach to prevent depression and anxiety, with scope to become a widescale public health strategy for preventing poor mental health and promoting well-being in young people.

• Study Type: Interventional
• Enrollment (Actual): 236
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United Kingdom
  • Devon
    • Exeter, Devon, United Kingdom, EX2 5DY
      • University of Exeter

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 16 years to 24 years (Child, Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• aged 16 to 24 years old (inclusive)
• currently based in the UK
• possess a basic literacy in English
• able to provide informed consent
• reporting elevated levels of worry and rumination, defined here as scoring above the 50th percentile (i.e., top-half of scale) on either the RSS (>34) or the PSWQ (>41)
• have regular access to a smartphone (android or iOS).

Exclusion Criteria:

• reporting highly elevated symptoms of depression indicating more specialist treatment is required (PHQ-9 > 20)
• self-report of active suicidality
• self-report currently receiving psychological therapy, counseling, or psychiatric medication, including antidepressants, for a current mental health condition

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Prevention
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Active Comparator: waiting list control group; Participants randomly allocated to this arm will be offered self-help components within a mobile phone app to target worry and rumination after a 6-week wait.	Device: digital CBT self-help including specific intervention elements to target worry and rumination.; The self-help app includes self-monitoring, psychoeducation and active self-help exercises. The self-monitoring includes daily mood ratings and an ecological momentary assessment option (MoodTracker) for more detailed analysis of mood, worry, activity and situational context. The digital self-help provides psychoeducation, tips, advice, exercises and training for each individual focused on reducing worry and rumination, using strategies from the proven rumination-focused CBT intervention. The app includes text, pictures, audio-recordings, animations, audio-exercises to practice (e.g., self-compassion, relaxation, concreteness exercises), and questionnaires with tailored feedback. The app is designed for iOS and Android use.; Other Names: MyMoodCoach
Experimental: treatment group; Participants randomly allocated to this arm will be offered self-help components within a mobile phone app to target worry and rumination immediately.	Device: digital CBT self-help including specific intervention elements to target worry and rumination.; The self-help app includes self-monitoring, psychoeducation and active self-help exercises. The self-monitoring includes daily mood ratings and an ecological momentary assessment option (MoodTracker) for more detailed analysis of mood, worry, activity and situational context. The digital self-help provides psychoeducation, tips, advice, exercises and training for each individual focused on reducing worry and rumination, using strategies from the proven rumination-focused CBT intervention. The app includes text, pictures, audio-recordings, animations, audio-exercises to practice (e.g., self-compassion, relaxation, concreteness exercises), and questionnaires with tailored feedback. The app is designed for iOS and Android use.; Other Names: MyMoodCoach

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change in rumination using the Ruminative Response Scale (RRS)	A well established 22-item measure of pathological rumination which predicts subsequent depression.	Change from baseline at 6 weeks

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change in worry using the Penn State Worry Questionnaire (PSWQ)	a well-validated 16-item measure of trait tendency towards worry	Change from baseline at 6 weeks
Change in symptoms for depression using the Patient Health Questionnaire-9 (PHQ-9)	a well-validated measure of depression and depressive symptoms	Change from baseline at 6 weeks
Change in wellbeing using the Warwick-Edinburgh Mental Well Being Scale (WEMWBS)	a leading validated self-reported index of well-being with excellent psychometric properties comprising 14 items	Change from baseline at 6 weeks
Change in symptoms for anxiety using the Generalized Anxiety Disorder-7 (GAD-7)	A well validated measure of anxiety and anxiety symptoms	Change from baseline at 6 weeks

Other Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change in worry using the Penn State Worry Questionnaire (PSWQ)	a well-validated 16-item measure of trait tendency towards worry	Change from 6 weeks post randomisation at 12 weeks post randomisation
Change in rumination using the Ruminative Response Scale (RRS)	A well established 22-item measure of pathological rumination which predicts subsequent depression.	Change from 6 weeks post randomisation at 12 weeks post randomisation
Change in symptoms for depression using the Patient Health Questionnaire-9 (PHQ-9)	a well-validated measure of depression and depressive symptoms	Change from 6 weeks post randomisation at 12 weeks post randomisation
Change in wellbeing using the Warwick-Edinburgh Mental Well Being Scale (WEMWBS)	a leading validated self-reported index of well-being with excellent psychometric properties comprising 14 items	Change from 6 weeks post randomisation at 12 weeks post randomisation
Change in symptoms for anxiety using the Generalized Anxiety Disorder-7 (GAD-7)	A well validated measure of anxiety and anxiety symptoms	Change from 6 weeks post randomisation at 12 weeks post randomisation

Collaborators and Investigators

• Sponsor: University of Exeter
• Investigators: Study Director: Ed R Watkins, Professor, Exeter University; Principal Investigator: Dan J Edge, MRes, Exeter University

Publications and helpful links

General Publications

• Edge D, Newbold A, Ehring T, Rosenkranz T, Frost M, Watkins ER. Reducing worry and rumination in young adults via a mobile phone app: study protocol of the ECoWeB (Emotional Competence for Well-Being in Young Adults) randomised controlled trial focused on repetitive negative thinking. BMC Psychiatry. 2021 Oct 21;21(1):519. doi: 10.1186/s12888-021-03536-0.

Study record dates

Study Major Dates

• Study Start (Actual): May 14, 2021
• Primary Completion (Actual): December 13, 2021
• Study Completion (Actual): January 30, 2022

Study Registration Dates

• First Submitted: June 22, 2021
• First Submitted That Met QC Criteria: July 2, 2021
• First Posted (Actual): July 6, 2021

Study Record Updates

• Last Update Posted (Actual): February 1, 2022
• Last Update Submitted That Met QC Criteria: January 30, 2022
• Last Verified: January 1, 2022

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Mental Disorders; Digestive System Diseases; Feeding and Eating Disorders; Gastrointestinal Diseases; Rumination Syndrome
• Other Study ID Numbers: eCLESPsy001977

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: YES
• IPD Plan Description: De-identified individual participant and clinical and economic data reported in publications will be made available through the University of Exeter's Institutional Repository - Open Research Exeter (see https://ore.exeter.ac.uk).

IPD Sharing Time Frame

The study protocol and informed consent form will be uploaded with this registration. The SAP is included in the study protocol.

Data Access: Post-analysis, the final anonymised dataset will preferentially be stored in Open Research Exeter (ORE), the University of Exeter's open access repository. The data will be available from 24 months after trial completion (end of December 2021).

• IPD Sharing Access Criteria: Access to these data is permitted but controlled through requests made via the repository to a review panel from the trial team, led by the chief investigator, which will assess requests on scientific merit and commercial sensitivity. Although use is permitted, this will be on the basis that the source of the data is acknowledged (including the funder) and it includes reference to the data set 'handle', and a data access agreement is signed, subject to approval by funder.
• IPD Sharing Supporting Information Type: STUDY_PROTOCOL; SAP; ICF

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No